Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Current Opinion in Rheumatology|June 25, 2015
Update on the immunobiology of Sjögren's syndromeAurélie Ambrosi, Marie Wahren-HerleniusArthritis Research & Therapy|May 2, 2012
Congenital heart block: evidence for a pathogenic role of maternal autoantibodiesAurélie Ambrosi, Marie Wahren-HerleniusEuropean Journal of Immunology|September 6, 2012
IL-17: a new actor in IFN-driven systemic autoimmune diseasesAurélie Ambrosi, Alexander Espinosa, Marie Wahren-HerleniusExperimental Cell Research|January 18, 2014
Molecular mechanisms of congenital heart blockAurélie Ambrosi, Sven-Erik Sonesson, Marie Wahren-HerleniusRheumatology (Oxford, England)|September 29, 2017
Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnanciesSven-Erik Sonesson, Malin Hedlund, Aurélie Ambrosi, et al.Annals of the Rheumatic Diseases|November 16, 2011
Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat modelAurélie Ambrosi, Vijole Dzikaite, Jeongsook Park, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 27, 2013
Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factorsMaria Sjöstrand, Aurélie Ambrosi, Susanna Brauner, et al.The Journal of Biological Chemistry|August 25, 2011
Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interfaceAlexander Espinosa, Janosch Hennig, Aurélie Ambrosi, et al.Annals of the Rheumatic Diseases|September 29, 2011
Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth patternAurélie Ambrosi, Stina Salomonsson, Håkan Eliasson, et al.Pageof 1